Category Archives: Supplement Studies

ANAHEIM, Calif.–Valensa introduced Zanthin® XP-3, an astaxanthin formulation  designed to provide optimal absorption to support of human health at lower levels of ingestion. It combines Valensas Zanthin® Natural Astaxanthin with a supercritical extract Perilla seed oil, O2B(TM) Peroxidation Blocker stabilization … Continue reading →

REDWOOD SHORES, CA, December 29, 2011 Vedic Lifesciences, a Contract Research Organization specializing in clinical trials for Nutraceutical and Cosmeceutical products announced today the completion of subject recruitment for a Human Growth Hormone Study. The product under trial is a … Continue reading →

Got an investment in a dietary-supplement company? You may want to be prepared to swallow a bitter pill. A recent Journal of the American Medical Association study found that vitamin E is not effective in preventing prostate cancer and in … Continue reading →

MPV now has Pro Tools 10 AVID Learning Partner Courseware. They tell us that these tutorial-videos are designed to supplement studies toward achieving Pro Tools 101 Certification. The company says you can also watch their collection of classic Pro Tools … Continue reading →

Dietary deficiencies are a significant problem in the United States, especially when fruits, vegetables, whole grains and other healthy foods are eaten in limited quantities. A study published in 2005 showed that many Americans were not meeting the US Recommended … Continue reading →

Those tracking dietary supplement regulations have had a busy summer. At the time I began writing this article, it had only been a few days since FDA had released its long-awaited new dietary ingredient (NDI) draft guidance. Moreover, just over … Continue reading →

In a release sent out today, acclaimed documentary filmmaker Ken Burns is speaking out in support of the Corporation for Public Broadcasting, in the face of proposed Congressional budget cuts. The proposed elimination of funding for the Corporation for Public … Continue reading →